mark

Mark Horowitz

Clinical Research Fellow in Psychiatry, UCL


I am a training psychiatrist and Clinical Research Fellow in Psychiatry North East London NHS Foundation Trust (NELFT) and an Honorary Clinical Research Fellow at UCL. I run a Psychotropic drug Deprescribing Clinic in North East London NHS Foundation Trust. I completed a PhD in the neurobiology of depression and the action of antidepressants at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London.

I am an Associate Editor of the journal Therapeutic Advances in Psychopharmacology. I co-authored the recent Royal College of Psychiatry guidance on ‘Stopping Antidepressants’, and my work has informed the recent NICE guidelines on safe tapering of psychiatric medications. I have written several papers about safe approaches to tapering psychiatric medications including publications in The Lancet Psychiatry, JAMA Psychiatry and Schizophrenia Bulletin.

I have an interest in rational psychopharmacology, the way in which psychiatric drugs are often mis-represented to the public and safely deprescribing these drugs. I have experienced the difficulty of coming off psychiatric medications first hand which has informed much of my work.

More from this expert

Misinformation about antidepressants and is probably fuelling their rise in use. Chief among these false ideas are

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.